Frontiers in public health · 2025
Endometriosis-related infertility in China: analysis of the global burden of disease study 2021.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lao Jianting, Shen Dongyi, Hu Panwei, Song Yanhua, Yang Hong
Аннотация
OBJECTIVE: Utilizing the Global Burden of Disease (GBD) 2021 dataset, this study analyzed temporal trends (1990-2021) and age-period-cohort patterns of endometriosis-related infertility burden in China versus globally. By employing joinpoint regression and APC modeling, we aimed to identify key epidemiological shifts and disparities, thereby providing evidence-based insights for optimizing health service planning and resource allocation strategies targeting endometriosis-related infertility.
METHODS: Using age-standardized prevalence rates (ASPR) of endometriosis-related infertility (1990-2021) from the GBD 2021 database, we analyzed Chinese females aged 15-49 years. Joinpoint regression identified significant trend changes in ASPR, while age-period-cohort (APC) modeling decomposed effects into age, period, and birth cohort dimensions using 5-year intervals.
RESULTS: In 2021, the age-standardized prevalence rate (ASPR) of patients with endometriosis-related primary infertility in China was 280.63 per 100,000 population (95% UI: 115.61 to 616.39). The percentage change in ASPR for endometriosis-associated primary infertility in China between 1990 and 2021 was -23.35% (95% UI: -10.52% to -32.68%) above the global level -29.61% (95% UI: -37.19% to -24.79%). In 2021, the ASPR of patients with endometriosis-associated secondary infertility in China was 1849.35 per 100,000 population (95% UI: 1104.61 to 2931.00). The percentage change of endometriosis-associated secondary between 1990 and 2021 ASPR in China was -38.16% (95% UI: -43.81% to -31.53%), below the global level -24.70% (95% UI: -27.99% to -21.11%).
CONCLUSION: The ASPR of endometriosis-related female infertility in China and globally declined between 1990 and 2021. This indicates that China has attained significant progress in addressing and managing endometriosis-related female infertility. However, the overall burden of endometriosis-related female infertility remains substantial and requires continued attention.
METHODS: Using age-standardized prevalence rates (ASPR) of endometriosis-related infertility (1990-2021) from the GBD 2021 database, we analyzed Chinese females aged 15-49 years. Joinpoint regression identified significant trend changes in ASPR, while age-period-cohort (APC) modeling decomposed effects into age, period, and birth cohort dimensions using 5-year intervals.
RESULTS: In 2021, the age-standardized prevalence rate (ASPR) of patients with endometriosis-related primary infertility in China was 280.63 per 100,000 population (95% UI: 115.61 to 616.39). The percentage change in ASPR for endometriosis-associated primary infertility in China between 1990 and 2021 was -23.35% (95% UI: -10.52% to -32.68%) above the global level -29.61% (95% UI: -37.19% to -24.79%). In 2021, the ASPR of patients with endometriosis-associated secondary infertility in China was 1849.35 per 100,000 population (95% UI: 1104.61 to 2931.00). The percentage change of endometriosis-associated secondary between 1990 and 2021 ASPR in China was -38.16% (95% UI: -43.81% to -31.53%), below the global level -24.70% (95% UI: -27.99% to -21.11%).
CONCLUSION: The ASPR of endometriosis-related female infertility in China and globally declined between 1990 and 2021. This indicates that China has attained significant progress in addressing and managing endometriosis-related female infertility. However, the overall burden of endometriosis-related female infertility remains substantial and requires continued attention.